| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/29/1996 | WO1996006188A1 Peptide librairies as a source of syngenes |
| 02/29/1996 | WO1996006185A1 Assay for the detection of proteases |
| 02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
| 02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | WO1996006166A1 Improvements in or relating to binding proteins for recognition of dna |
| 02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006116A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996006109A1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 02/29/1996 | WO1996006108A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same |
| 02/29/1996 | WO1996006107A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 02/29/1996 | WO1996005866A2 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 02/29/1996 | WO1996005861A1 Compositions and methods for the treatment of body weight disorders, including obesity |
| 02/29/1996 | WO1996005860A1 A method of treating a patient with a biologically active compound |
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005855A1 Cartilage disease remedy |
| 02/29/1996 | WO1996005854A2 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 02/29/1996 | WO1996005853A1 TREATMENT OF IgA NEPHROPATHY |
| 02/29/1996 | WO1996005852A1 Treatment of inflammatory diseases of the gastro-intestinal tract |
| 02/29/1996 | WO1996005851A1 Use of tasteless, hydrolysed collagen and agent containing the same |
| 02/29/1996 | WO1996005850A1 Cytokine regulation of cellular senescence |
| 02/29/1996 | WO1996005838A2 Combined preparation for the therapy of immune diseases |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/29/1996 | WO1996005797A2 Agent for external application with nutrient and protective properties |
| 02/29/1996 | WO1995032735A3 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
| 02/29/1996 | DE4431401A1 Lebendvakzine gegen Tumorerkrankungen Live vaccines against tumors |
| 02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
| 02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
| 02/29/1996 | CA2199949A1 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 02/29/1996 | CA2198352A1 Assay for the detection of proteases |
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
| 02/29/1996 | CA2198234A1 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | CA2198219A1 Human chemokine polypeptides |
| 02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | CA2197864A1 Peptide libraries as a source of syngenes |
| 02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | CA2197577A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2196547A1 Agent for external application with nutrient and protective properties |
| 02/29/1996 | CA2196311A1 Genetically engineered swine cells |
| 02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | CA2174534A1 Recombinant dnase b derived from streptococcus pyogenes |
| 02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
| 02/28/1996 | EP0698616A1 Process for the preparation of a C1-esterase inhibitor (C1-1NH) concentrate and therapeutical use thereof |
| 02/28/1996 | EP0698615A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
| 02/28/1996 | EP0698613A1 Endothelin-antagonizing peptide |
| 02/28/1996 | EP0698203A1 Method for selective opening of abnormal brain tissue capillaries |
| 02/28/1996 | EP0698123A1 Means for detecting familial colon cancer (fcc) |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
| 02/28/1996 | EP0698095A1 Bmp-10 compositions |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
| 02/28/1996 | EP0698040A1 Lhrh antagonists |
| 02/28/1996 | EP0698039A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
| 02/28/1996 | EP0698038A1 Method of separating glycosylated and non-glycosylated proteins |
| 02/28/1996 | EP0698031A1 SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION |
| 02/28/1996 | EP0698015A1 Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0697887A1 Stable liquid compositions of gamma interferon |
| 02/28/1996 | EP0697886A1 New peptide antagonists at glutamate and nmda receptors |
| 02/28/1996 | EP0697885A1 Insulin-like growth factor ii as antitumour agent |
| 02/28/1996 | EP0697883A1 Use of platelet-derived growth factor to improve collateral circulation |
| 02/28/1996 | EP0697882A1 Use of glutathione diesters |
| 02/28/1996 | EP0697881A1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0697879A1 Cyclohexapeptidyl aminoalkyl ethers |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/28/1996 | EP0697874A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| 02/28/1996 | EP0697857A1 Hookworm anticoagulant |
| 02/28/1996 | EP0659184B1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117743A Method to predict active growth of bacteria adhered to a surface |
| 02/28/1996 | CN1117492A Treatment of H. pylori infections |
| 02/27/1996 | US5495047 Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 02/27/1996 | US5495006 Antiviral polynucleotide conjugates |
| 02/27/1996 | US5495002 Tumor associated monoclonal antibody 123AV16 |
| 02/27/1996 | US5495001 Recombinant purified protease nexin |
| 02/27/1996 | US5495000 Anticoagulant peptides |
| 02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
| 02/27/1996 | US5494919 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
| 02/27/1996 | US5494899 Immunomodulation of bone marrow cells in culture using hormones during pregnancy, such as estrogen; autoimmune disorders, osteoporosis |